Library
5F-AMB-PICA
MMB-2201 is a potent indole-3-carboxamide based synthetic cannabinoid, which has been sold as a designer drug and as an active ingredient in synthetic cannabis blends. It was first reported in Russia and Belarus in January 2014, but has since been sold in a number of other countries. In the United States, MMB-2201 was identified in Drug Enforcement Administration drug seizures for the first time in 2018.
Also known as: 5F-AMB-PICA (MMB-2201), methyl (1-(5-fluoropentyl)-1 H-indole-3-carbonyl)-L-valinate